BackCorMedix Overview
CorMedix Inc

CorMedix Target Price

Analysts' average 12-month price target for CorMedix is $15.

Get informed when a big investor buys or sells

+ Follow

Share Price

$7.19

Average Target Price

$15.00108.6% upside

1 analysts in the last 4 months

High: $15 | Low: $15

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-23OppenheimerLes Sulewski$15108.6% upsideOpen
2026-04-28RBC CapitalLeonid Timashev$1494.7% upsideOpen
2026-03-06Leerink PartnersRoanna Ruiz$1380.8% upsideOpen
2026-01-23H.C. Wainwright$1380.8% upsideOpen
2026-01-21RBC Capital$1380.8% upsideOpen
2026-01-08Truist Financial$16122.5% upsideOpen
2025-10-21RBC CapitalGregory Renza$22206% upsideOpen
2025-08-08H.C. WainwrightBrandon Folkes$17136.4% upsideOpen
2024-03-13RBC CapitalGregory Renza$925.2% upsideOpen

CorMedix (CRMD) FAQ

As of the most recent data, CRMD shows a target price of $15. Scroll down for historical charts and peer comparison views.

If CorMedix moved to the average analyst target of $15, shares would be roughly 108.6% higher than $7.19. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of CorMedix's earnings trajectory.

Besides this target price page, Stockcircle has CorMedix's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $15) with ownership activity and broader fundamentals.

CorMedix's target price is $15; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.